RNA-i test vector, p2FP-RNAi

cat.# FP981

The vector sequence has been compiled using the information from sequence databases, published literature, and other sources, together with partial sequences obtained by Evrogen. This vector has not been completely sequenced.


Download
vector information:
ProductCat.#SizePrice
p2FP-RNAi vectorFP98120 μg€ 400
Price does not include delivery. Please contact your local distributor for exact prices and delivery information.

Vector typemammalian expression vector
ReportersTurboGFP / JRed-Neor fusion
Reporter codon usagemammalian
Promoters for TurboGFP and JRed-NeorPCMV IE
Host cells mammalian
Selection prokaryotic - kanamycin / eukaryotic - neomycin (G418)
ReplicationpUC ori
UseRNAi test vector

Multiple cloning site

TurboGFP Bgl II Sac I Sal I Sma I/Xma I
Stop Xho I* Hind III Kpn I
GT.GAA.GAA. TGA .TCC.CGG.A AG.AT C.T C G.AG C.TC A.AGC.TT C G.TCG.AC G.GTA.CC G. CCC.GGG. ACT.

* - not unique site

Description

p2FP-RNAi vector is a mammalian expression vector encoding two fluorescent proteins: TurboGFP and JRed-neomycin phosphotransferase II protein fusion (JRed-Neor). Both proteins are under the control of immediate early promoter of cytomegalovirus (PCMV IE): the first regulates TurboGFP expression, while the second provides JRed-Neor expression. Codon usages of both reporters are optimized for high expression in mammalian cells (Haas et al., 1996). To increase TurboGFP mRNA translation efficiency, Kozak consensus translation initiation site is generated upstream of TurboGFP coding sequence (Kozak, 1987).

Multiple cloning site (MCS) is located between the TurboGFP stop codon and SV40 polyadenylation signals (SV40 poly A) allowing to clone a DNA fragment of interest into the TurboGFP 3' untranslated region (3'UTR). SV40 poly A direct proper processing of the 3' end of TurboGFP mRNA.

    Note: The plasmid DNA was isolated from dam+-methylated E. coli. Therefore some restriction sites are bloked by methylation. If you wish to digest the vector using such sites you will need to transform the vector into a dam host and make fresh DNA.

The vector backbone also contains pUC origin of replication for propagation in E. coli, and f1 origin for single-stranded DNA production. Bacterial promoter (PT5/LacO) allows the expression of kanamycin resistance gene (fusion with JRed) in E. coli. Kanr/Neor-JRed fusion gene is linked with herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signals.

Expression in mammalian cells

The vector can be transfected into mammalian cells using any standard transfection method. If required, stable transformants can be selected using G418 (Gorman, 1985). When transfected into eukaryotic cells in the absence of a functional siRNA, the vector expresses both JRed and TurboGFP proteins. In this case intensity of green fluorescence prevails significantly over the red signal.

TurboGFP expression is knocked down in the presence of siRNA(s) directed against the cloned DNA fragment. JRed expression at that remains unmodified or (in some experimental systems) increases because of translational competition.

    Note: Because of lower phosphotransferase activity of the JRed-Neor fusion protein in comparison with neomycin phosphotransferase II alone, working concentration of the neomycin for cultivation of mammalian cells comprising p2FP-RNAi vector must be 2-4 fold lower than standard one for cells with neomycin resistance.
Propagation in E. coli

Suitable host strains for propagation in E. coli include DH5alpha, HB101, XL1-Blue, and other general purpose strains. Plasmid incompatibility group is pMB1/ColE1. The vector confers resistance to kanamycin (10 mg/ml) to E. coli hosts. Copy number in E. coli is about 500.

    Note: The working concentration of the kanamycin should be 2-4 fold lower that standard one for vectors with Kanr/Neor resistance.

Location of features

PCMV IE: 1-589
Enhancer region: 59-465
TATA box: 554-560
Transcription start point: 583
TurboGFP Kozak consensus translation initiation site: 606-616
Start codon (ATG): 613-615
Stop codon: 1309-1311
MCS: 1312-1360
Polyadenylation signals: 1505-1510 & 1534-1539
mRNA 3' ends: 1543 & 1555
f1 single-strand DNA origin: 1602-2057 (Packages the noncoding strand of TurboGFP.)
PCMV IE: 2231-2812
Enhancer region: 2282-2688
TATA box: 2777-2783
Transcription start point: 2806
T5 promoter/lac operator element: 2894-2974
T5 transcription start: 2948
JRed-Neor
Start codon (ATG): 3002-3004
JRed: 3038-3760
Kanamycin/neomycin resistance gene: 3785-4576
Stop codon: 4574-4576
Herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signal
Polyadenylation signals: 4812-4817 & 4825-4830
pUC plasmid replication origin: 5161-5804

References:

  • Gorman (1985) In DNA cloning: A Practical Approach, Vol. II. Ed. D. M. Glover. (IRL Press, Oxford, U.K.), pp. 143-190.
  • Haas et al. (1996) Curr. Biol. 6: 315-324.
  • Kozak, M. (1987) An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15:8125–8148.

Notice to Purchaser:

Evrogen FP-related products are intended for research use only and covered by Evrogen Patents and/or Patent applications pending. By use of these products, you accept the terms and conditions of the applicable Limited Use Label License.

The CMV promoter is covered under U.S. Patents 5,168,062 and 5,385,839, and its use is permitted for research purposes only. Any other use of the CMV promoter requires a license from the University of Iowa Research Foundation, 214 Technology Innovation Center, Iowa City, IA 52242.

MATERIAL SAFETY DATA SHEET INFORMATION

To the best of our knowledge, these products do not require a Material Safety Data Sheet. However, all the properties of these products (and, if applicable, each of their components) have not been thoroughly investigated. Therefore, we recommend that you use gloves and eye protection, and wear a laboratory coat when working with these products.

Copyright 2002-2008 Evrogen. All rights reserved.
Evrogen JSC, 16/10 Miklukho-Maklaya str., Moscow, Russia, +7(495)4298020, e-mail:evrogen@evrogen.com